Cargando…
Performance Evaluation of Lateral Flow Assays for Coronavirus Disease-19 Serology
The coronavirus disease of 2019 (COVID-19) pandemic, caused by infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has undoubtedly resulted in significant morbidities, mortalities, and economic disruptions across the globe. Affordable and scalable tools to monitor the tr...
Autores principales: | Ochola, Lucy, Ogongo, Paul, Mungai, Samuel, Gitaka, Jesse, Suliman, Sara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563367/ https://www.ncbi.nlm.nih.gov/pubmed/35153047 http://dx.doi.org/10.1016/j.cll.2021.10.005 |
Ejemplares similares
-
Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2
por: Trombetta, Bianca A., et al.
Publicado: (2021) -
Correction to: Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2
por: Trombetta, Bianca A., et al.
Publicado: (2021) -
Pre-evaluation assessment of serological-based COVID-19 point-of-care lateral flow assays in Kenya
por: Kimotho, James H., et al.
Publicado: (2021) -
Evaluating ELISA, Immunofluorescence, and Lateral Flow Assay for SARS-CoV-2 Serologic Assays
por: Michel, Moïse, et al.
Publicado: (2020) -
Coronavirus Disease 2019 Diagnostics: Key to Africa's Recovery
por: Naidoo, Sanushka, et al.
Publicado: (2022)